Abiomed, Inc. provided earnings guidance for the fiscal year 2023. For the period, the company expects revenue to be in the range $1.13 billion and $1.17 billion or 10% to 14% growth compared to fiscal year 2022.
Abiomed, Inc.
Equities
ABMD
US0036541003
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+7.87% | 219B | |
+11.83% | 192B | |
+18.87% | 142B | |
+30.03% | 111B | |
+2.36% | 65.32B | |
+14.15% | 52.45B | |
+2.68% | 49.8B | |
+6.60% | 43.43B | |
+1.85% | 35.95B |